What You Need to Know:
- Boston-based Biofourmis’ AI-powered digital therapeutics technology has inked a deal with The University of Hong Kong and Hong Kong’s Department of Health to leverage its wearable, AI-powered remote monitoring platform to provide new insights to fight COVID-19 in a national disease monitoring program.
- Biofourmis’ technology will remotely monitor coronavirus infected and suspected patients and apply personally predictive analytics to help patients and increase
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Precision Health Startup Q Bio Emerges Out of Stealth with $40M Led by Andreessen Horowitz
- Precision health startup Q Bio emerges out of stealth mode, raising $40M in Series B funding led by Andreessen Horowitz to bring preventative health and the physical of the future to masses.
- In 75 minutes or less, members are able to get a comprehensive picture of their health and receive a web-based dashboard that they can review from anywhere in the world with their chosen clinicians.
Q Bio, a Redwood
City, CA-based quantitative, clinically relevant assessment of personal
Read More
Notable Launches Observational Clinical Trial for Patients with Blood Cancer
- Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More
7 Trends Impacting The Design of Healthcare Environments in 2020
SmithGroup one of the nation’s leading integrated design firms has tapped its broad network of 1,300 interdisciplinary design professionals to offer its predictions for the trends and challenges that the design industry will face in the decade ahead. Here are seven trends that are likely to impact the design of health care environments in the 2020s. 1. Adapting to the Climate Crisis“In the last couple of years, the impacts of climate change are increasingly viewed as a global crisis, and I
Read More
Paige Raises $45M to Expand AI-Native Digital Pathology Ecosystem to Accelerate Biomarker Discovery
- Paige raises $45M in Series B funding led by Healthcare Venture Partners with participation from Breyer Capital, Kenan Turnacioglu, and others. - The funding will be used to accelerate commercial efforts of its AI-native digital pathology ecosystem in the U.S., Europe, Brazil, and Canada. Paige, a NYC-based leader in computational pathology transforming the diagnosis and treatment of cancer, today announced it has closed its Series B funding round of $45 million, bringing the Company’s
Read More
Social Determinants of Health Trends in 2020: The End of the Beginning?
2020 will mark the end of the beginning of Social Determinants of Health (SDoH).
One would be remiss not to give pause and to consider how much time it has taken to get to this pivotal period in US health and healthcare delivery and, focus on the cornerstone “why” healthcare must, with a fierce urgency, step into the twenty-first century of US healthcare delivery. Meaning, it has taken nearly seventy years to go from the World Health Organization identifying the profundity of SDoH influence on
Read More
10 Factors Radiologists Should Consider When Selecting AI Vendors
With over 150 independent software vendors developing machine learning solutions for medical imaging, sorting through the plethora of options to select vendors is a challenge. Here are 10 factors radiologists should consider (and questions they should ask) before partnering with vendors providing AI solutions for medical imaging.
1. Clinical Relevancy
The foremost consideration for healthcare providers adopting AI into their clinical workflow is relevancy. Does the AI solution truly
Read More
Life Image, Graticule Launches Imaging Dataset In AWS Data Exchange
- Life Image and Graticule announced the availability of GLIMPS (Graticule Life Image Machine Parsed Set) data licensing subscriptions in AWS Data Exchange. - GLIMPS (Graticule Life Image Machine Parsed Set) is a de-identified patient-level data set including a summary of features generated from NLP processing on Life Image data. - The goal of GLIMPS is to provide a cost-effective patient-level snapshot to biopharma data science teams to fuel the necessary discussions about these data, leading
Read More
Philips, Dept. of Defense Partner to Develop AI-Algorithm to Detect Infection 48 Hours Before Observable Symptoms
- Philips and the U.S. Department of Defense are teaming up to develop an AI-algorithm to identify infection more than 48 hours before observable symptoms.
- Using large data sets & machine learning across biomarkers, innovative tech can speed time to detection, intervention & treatment, while improving outcomes & reducing the spread of disease.
- Future research is currently being planned to leverage this information as an algorithm to be integrated into a wearable device,
Read More
